Alice L Bhasale (Alice Bhasale)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Coronary Artery

Transcription Factor

Cross Sectional

Health Insurance

Top Venues

Expert opinion on drug safety

Clinical pharmacology and therapeutics

British journal of clinical pharmacology

Internal medicine journal

This page only lists publications with an associated author ORCID identifier.

Publications

Barbara J Mintzes, Ellen Reynolds, Priya Bahri, Lucy T Perry, Alice L Bhasale, Richard L Morrow, Colin R Dormuth
How do safety warnings on medicines affect prescribing? Expert opinion on drug safety 21 (10) (2022)
Alice L Bhasale, Ameet Sarpatwari, Wendy Lipworth, Mathias Møllebaek, Eliza J McEwin, Nileesa Gautam, Adrian Santiago Ortiz, Barbara J Mintzes
Regulatory authority and clinical acceptability: Physicians' responses to regulatory drug safety warnings. British journal of clinical pharmacology (2021)
Barbara J Mintzes, Alice L Bhasale, Marc Torka, Ruth Lopert, Sallie-Anne Pearson, Joel R Lexchin, Lisa A Bero
A sorry tale of unnecessary secrecy about medicine safety. Internal medicine journal 51 (10) (2021)
Ashleigh Hooimeyer, Alice L Bhasale, Lucy T Perry, Alice Fabbri, Annim Mohammad, Eliza McEwin, Barbara J Mintzes
Regulatory post-market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies. Pharmacology research & perspectives 8 (6) (2021)
Lucy T Perry, Alice L Bhasale, Alice Fabbri, Joel R Lexchin, Lorri Puil, Maisah Joarder, Barbara J Mintzes
A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016. Pharmacoepidemiology and drug safety 29 (9) (2020)
Alice L Bhasale, Ameet Sarpatwari, Marie Louise De Bruin, Joel R Lexchin, Ruth Lopert, Priya Bahri, Barbara J Mintzes
Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United States. Clinical pharmacology and therapeutics 109 (6) (2020)